GU

Browse all GU
Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer

GU

Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer

Thomas Powles, MD, MBBS, MRCP

GI

Browse all GI
FDA Approval of Cabozantinib in Neuroendocrine Tumors

GI

FDA Approval of Cabozantinib in Neuroendocrine Tumors

Aman Chauhan, MD

LUNG CANCER

Browse all LUNG CANCER
FDA Approval of Zongertinib in HER2-Mutated NSCLC

LUNG CANCER

FDA Approval of Zongertinib in HER2-Mutated NSCLC

Joshua Sabari, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

FDA Approves Dato-DXd for Patients With EGFR-Mutated NSCLC

LUNG CANCER

FDA Approves Dato-DXd for Patients With EGFR-Mutated NSCLC

Jacob Sands, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD